155 related articles for article (PubMed ID: 15324577)
1. [Combine low-dose heparin with prostaglandin E1 and Dextran 40 to prevent and treat hepatic veno-occlusive disease after hematopoietic stem cell transplantation].
Li QP; Zhu WG; Yin XJ; Feng ZC
Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):537-8. PubMed ID: 15324577
[No Abstract] [Full Text] [Related]
2. [Preventive effect of integrated Chinese and Western medicine on hepatic veno-occlusive disease after hematopoietic stem cell transplantation].
Liu J; Zhang X; Chen XH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Oct; 30(10):1049-51. PubMed ID: 21066888
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic low-dose heparin or prostaglandin E1 may prevent severe veno-occlusive disease of the liver after allogeneic hematopoietic stem cell transplantation in Korean children.
Song JS; Seo JJ; Moon HN; Ghim T; Im HJ
J Korean Med Sci; 2006 Oct; 21(5):897-903. PubMed ID: 17043426
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of low-dose heparin and prostaglandin E1 in the prevention of hepatic veno-occlusive disease after allogenic hematopoietic stem cell transplantation in children with beta-thalassemia major].
Sun X; Hao WG; Liu S; Xia T; Liao C
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):343-6. PubMed ID: 17706036
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis and treatment of hepatic veno-occlusive disease after pediatric stem cell transplantation.
Tsakiris DA
Haematologica; 2006 Jun; 91(6):726B. PubMed ID: 16769572
[No Abstract] [Full Text] [Related]
6. Venous occlusive disease in children.
Gharib MI; Bulley SR; Doyle JJ; Wynn RF
Thromb Res; 2006; 118(1):27-38. PubMed ID: 16154622
[No Abstract] [Full Text] [Related]
7. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
8. [Prophylaxis of hepatic veno-occlusive disease by low-molecular-weight heparin and lipo- prostaglandin E1 after allogeneic peripheral blood stem cell transplantation].
Song CY; Li YH; Guo KY; Wu BY
Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):494, 497. PubMed ID: 12754143
[TBL] [Abstract][Full Text] [Related]
9. [Low dose heparin for the prevention of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation].
Chen J; Zhu KE; Zhang T; Zhong J; Chen ST; Zeng HL
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):140-2. PubMed ID: 17445443
[TBL] [Abstract][Full Text] [Related]
10. Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution.
Lakshminarayanan S; Sahdev I; Goyal M; Vlachos A; Atlas M; Lipton JM
Pediatr Transplant; 2010 Aug; 14(5):618-21. PubMed ID: 20051023
[TBL] [Abstract][Full Text] [Related]
11. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation.
Chalandon Y; Roosnek E; Mermillod B; Newton A; Ozsahin H; Wacker P; Helg C; Chapuis B
Biol Blood Marrow Transplant; 2004 May; 10(5):347-54. PubMed ID: 15111934
[TBL] [Abstract][Full Text] [Related]
12. [Efficiency of prevention and treatment of veno-occlusive disease of the liver after allogeneic stem cell transplantation].
Dong M; Lin Q; Wu XY
Ai Zheng; 2008 Jun; 27(6):646-9. PubMed ID: 18570742
[TBL] [Abstract][Full Text] [Related]
13. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy.
Haussmann U; Fischer J; Eber S; Scherer F; Seger R; Gungor T
Haematologica; 2006 Jun; 91(6):795-800. PubMed ID: 16769582
[TBL] [Abstract][Full Text] [Related]
14. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.
Corbacioglu S; Cesaro S; Faraci M; Valteau-Couanet D; Gruhn B; Rovelli A; Boelens JJ; Hewitt A; Schrum J; Schulz AS; Müller I; Stein J; Wynn R; Greil J; Sykora KW; Matthes-Martin S; Führer M; O'Meara A; Toporski J; Sedlacek P; Schlegel PG; Ehlert K; Fasth A; Winiarski J; Arvidson J; Mauz-Körholz C; Ozsahin H; Schrauder A; Bader P; Massaro J; D'Agostino R; Hoyle M; Iacobelli M; Debatin KM; Peters C; Dini G
Lancet; 2012 Apr; 379(9823):1301-9. PubMed ID: 22364685
[TBL] [Abstract][Full Text] [Related]
15. Optimal approach to prevent veno-occlusive disease following hematopoietic stem cell transplantation in children.
Hassan Z
Pediatr Transplant; 2010 Sep; 14(6):683-7. PubMed ID: 20353406
[No Abstract] [Full Text] [Related]
16. Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children.
Naples JC; Skeens MA; Auletta J; Rangarajan H; Abu-Arja R; Horwitz E; Stanek J; Bajwa RS
Bone Marrow Transplant; 2016 Jan; 51(1):135-7. PubMed ID: 26367232
[No Abstract] [Full Text] [Related]
17. [Hepatic veno-occlusive disease after hematopoietic stem cell transplantation in 23 patients].
Du H; Yang DL; Huang Y; Wang H; Wang M; Zhou Z; Zhai WJ; Feng SZ; Han MZ
Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):949-50. PubMed ID: 18171540
[No Abstract] [Full Text] [Related]
18. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
[TBL] [Abstract][Full Text] [Related]
19. [Prevention of hepatic veno-occlusive disease by a combination of heparin and prostaglandin E1 in children undergoing hematopoietic stem cell transplantation].
Inukai T; Sugita K; Goi K; Akahane K; Hirose K; Nemoto A; Takahashi K; Sato H; Uno K; Furuichi Y; Nakamura M; Miyamoto N; Yamakawa N; Shiraishi K; Kojika S; Tezuka T; Iijima K; Nakazawa S
Rinsho Ketsueki; 2004 Apr; 45(4):297-303. PubMed ID: 15168445
[TBL] [Abstract][Full Text] [Related]
20. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Cesaro S; Pillon M; Talenti E; Toffolutti T; Calore E; Tridello G; Strugo L; Destro R; Gazzola MV; Varotto S; Errigo G; Carli M; Zanesco L; Messina C
Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
